Leonard M. Greenstein, Chief Financial Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 5,313 shares at $13.44 ($71K) on 2023-03-16, disclosed to the SEC on 2023-03-17.
Open-market sale of $71k TARS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.43 | 313 | $4K | 5.9% |
| 2 | $13.44 | 5,000 | $67K | 94.1% |
| Total | $13.44 avg | 5,313 | $71K | 100% |
| Filing → |
| TARS | SELL | 2023-03-21 | $8K | — | Filing → |
| TARS | SELL | 2023-02-17 | $76K | — | Filing → |
| TARS | SELL | 2023-01-20 | $73K | — | Filing → |